Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Alsaad HA"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Assessment of self-medication practice and the potential to use a mobile app to ensure safe and effective self-medication among the public in Saudi Arabia.
Autorzy:
Alsaad HA; Department of Pharmacology and Toxicology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Almahdi JS; College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Alsalameen NA; College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Alomar FA; Department of Pharmacology and Toxicology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Islam MA; Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Pokaż więcej
Źródło:
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2022 Jul; Vol. 30 (7), pp. 927-933. Date of Electronic Publication: 2022 May 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients.
Autorzy:
Alomar FA; Department of Pharmacology and Toxicology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P. O. Box 1982, Dammam, 31441, Saudi Arabia. .
Alshakhs MN; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
Abohelaika S; Clinical Pharmacology Department, Qatif Central Hospital, Ministry of Health, Qatif, Saudi Arabia.
Almarzouk HM; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
Almualim M; Intenstive Care Unit, Qatif Central Hospital, Ministry of Health, Qatif, Saudi Arabia.
Al-Ali AK; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Al-Muhanna F; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Alomar MF; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Alhaddad MJ; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
Almulaify MS; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
Alessa FS; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
Alsalman AS; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
Alaswad A; Clinical Pharmacology Department, Qatif Central Hospital, Ministry of Health, Qatif, Saudi Arabia.
Bidasee SR; Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Alsaad HA; Department of Pharmacology and Toxicology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P. O. Box 1982, Dammam, 31441, Saudi Arabia.
Alali RA; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
AlSheikh MH; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Akhtar MS; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Al Mohaini M; Basic Sciences Department, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Al Ahsa, 31982, Saudi Arabia.
Alsalman AJ; Department of Clinical Pharmacy, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
Alturaifi H; King Fahad Hospital Hofuf, Alahsa, Saudi Arabia.
Bidasee KR; Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jun 09; Vol. 12 (1), pp. 9510. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Intensive Care Units*
Biomarkers ; Glycolysis ; Humans ; Pyruvaldehyde
Czasopismo naukowe
Tytuł:
In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.
Autorzy:
Alsaad HA; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198-5800, USA.
DeKorver NW; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198-5800, USA.
Mao Z; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198-5800, USA.
Dravid SM; Department of Pharmacology, Creighton University, Omaha, NE, USA.
Arikkath J; Department of Developmental Neuroscience, Monroe Meyer Institute, University of Nebraska Medical Center, Omaha, NE, USA.
Monaghan DT; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198-5800, USA. .
Pokaż więcej
Źródło:
Neurochemical research [Neurochem Res] 2019 Jan; Vol. 44 (1), pp. 61-77. Date of Electronic Publication: 2018 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Interneurons/*metabolism
Neuroglia/*metabolism
RNA, Messenger/*biosynthesis
Receptors, N-Methyl-D-Aspartate/*biosynthesis
Telencephalon/*metabolism
Animals ; Gene Expression ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Protein Subunits/biosynthesis ; Protein Subunits/genetics ; RNA, Messenger/genetics ; Receptors, N-Methyl-D-Aspartate/genetics
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies